Pharmaceutical Technology5d
GCC-4001 by Artiva Biotherapeutics for Rheumatoid Arthritis: Likelihood of Approval
GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.
The Pharma Letter7d
GSK’s Nucala wins wider approval in China
China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody from UK ...
GSK’s Nucala approved in China as add-on therapy for adults with CRSwNP
GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that targets ...
Pharmaceutical Technology11d
Iptacopan hydrochloride by Novartis for Microscopic Polyangiitis (MPA): Likelihood of Approval
Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase II for Microscopic Polyangiitis (MPA).
Two children with rare autoimmune diseases get a new lease of life
The girl, who was admitted to Aster CMI Hospital with alarming breathlessness and significant pallor, was diagnosed with ...